These Healthcare stocks are trading higher:
-CTI BioPharma Corp (CTIC) stock is trading at $8.93, an increase of $4.11, or 85.17%, on high volume. Cti Biopharm Corp gets a Sentiment Score of Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $10.73. Cti Biopharm Corp next reports earnings on May 11.
-Corvus Pharmaceuticals Inc (CRVS) stock is trading at $1.67, an increase of $0.38, or 28.96%, on high volume. Corvus Pharma Com gets a Sentiment Score of Very Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $2.83.
-Cano Health Inc (CANO) stock is trading at $1.32, a rise of $0.27, or 25.71%, on high volume. Cano Health Inc gets a Sentiment Score of Bearish from InvestorsObserver and receives an average analyst recommendation of Buy with a price target of $3.71.
-Sharps Technology Inc (STSS) stock is trading at $1.21, a gain of $0.23, or 24.83%, on high volume. Sharps Technology Inc gets a Sentiment Score of Bullish from InvestorsObserver.
Find the top stocks in the Healthcare Sector here.
These Healthcare stocks are trading lower:
-Babylon Holdings Ltd (BBLN) stock is trading at $2.12, a loss of $4.96, or 70.06%, on high volume. Babylon Hldgs Ltd gets a Sentiment Score of Very Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $14.75.
-SeaStar Medical Holding Corp (ICU) stock is trading at $1.27, a decline of $0.67, or 34.54%, on high volume. Seastar Medical Hldg Corp gets a Sentiment Score of Very Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $5.00.
-Cytek Biosciences Inc (CTKB) stock is trading at $8.80, a loss of $2.87, or 24.51%, on high volume. Cytek Biosciences Inc gets a Sentiment Score of Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $15.00.
-Vyne Therapeutics Inc (VYNE) stock is trading at $6.13, a drop of $1.66, or 21.34%, on low volume. Vyne Therapeutics Inc gets a Sentiment Score of Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $63.29. Vyne Therapeutics Inc next reports earnings on May 11.
Find the top stocks in the Healthcare Sector here.